The Board proposes the rule amendment to update language regarding the addition of training for compounding sterile and/or nonsterile human drugs as an option for acquiring the hours required for consultant pharmacist license renewal continuing ...  

  •  

    DEPARTMENT OF HEALTH

    Board of Pharmacy

    RULE NO.:RULE TITLE:

    64B16-26.302Subject Matter for Consultant Pharmacist Licensure Renewal Continuing Education

    PURPOSE AND EFFECT: The Board proposes the rule amendment to update language regarding the addition of training for compounding sterile and/or nonsterile human drugs as an option for acquiring the hours required for consultant pharmacist license renewal continuing education.

    SUMMARY: Language will be updated regarding the addition of training regarding compounding sterile and/or nonsterile human drugs as an option for acquiring the hours required for consultant pharmacist license renewal continuing education.

    SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION:

    The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency.

    The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: During discussion of the economic impact of this rule at its Board meeting, the Board, based upon the expertise and experience of its members, determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary and that the rule will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time.

    Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

    RULEMAKING AUTHORITY: 465.005, 465.0125 FS.

    LAW IMPLEMENTED: 465.0125 FS.

    IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.

    THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Jennifer Wenhold, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin C04, Tallahassee, Florida 32399-3254.

     

    THE FULL TEXT OF THE PROPOSED RULE IS:

     

    64B16-26.302 Subject Matter for Consultant Pharmacist Licensure Renewal Continuing Education.

    A Consultant Pharmacist License Renewal Continuing Education Program must contain at least three (3) hours of training in any of the subjects specified below. Duplicate courses are not acceptable.

    (1) through (3) No change.

    (4) Compounding sterile or nonsterile human drugs, or both.

    Rulemaking Authority 465.005, 465.012, 465.0125 FS. Law Implemented 465.012 465.0125 FS. History–New 10-14-91, Formerly 21S-26.302, 61F10-26.302, 59X-26.302, Amended 5-5-05, 7-21-09,                    .

     

    NAME OF PERSON ORIGINATING PROPOSED RULE: Board of Pharmacy

    NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Pharmacy

    DATE PROPOSED RULE APPROVED BY AGENCY HEAD: October 15, 2019

    DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: November 6, 2019

Document Information

Comments Open:
12/3/2019
Summary:
Language will be updated regarding the addition of training regarding compounding sterile and/or nonsterile human drugs as an option for acquiring the hours required for consultant pharmacist license renewal continuing education.
Purpose:
The Board proposes the rule amendment to update language regarding the addition of training for compounding sterile and/or nonsterile human drugs as an option for acquiring the hours required for consultant pharmacist license renewal continuing education.
Rulemaking Authority:
465.005, 465.0125 FS.
Law:
465.0125 FS.
Contact:
Jennifer Wenhold, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin C04, Tallahassee, Florida 32399-3254.
Related Rules: (1)
64B16-26.302. Subject Matter for Consultant Pharmacist Licensure Renewal Continuing Education